AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Sitawalk 50mg/500mg Tablet

Prescription Icon
Prescription Required

Marketer

Cagrus Biopharma

Salt Composition

Sitagliptin (50mg) + Metformin (500mg)

Overview Sitawalk 50mg/500mg Tablet

Diabex Duo 50mg/500mg tablets combine two medications to effectively manage elevated blood glucose in individuals with type 2 diabetes. This dual action helps prevent serious diabetic complications like vision impairment and kidney disease, potentially lowering the risk of stroke and heart attack. Diabex Duo may be used as a standalone treatment or in conjunction with other diabetes medications. Optimal results are achieved with a balanced diet and regular physical activity. Dosage is personalized based on your health status, blood sugar readings, and current medications. Consuming the tablet with food minimizes stomach upset. Consistent daily dosing at the same time maximizes therapeutic benefits; discontinuation should only occur under your doctor's guidance. Adherence to your prescribed diet and exercise plan is crucial for successful diabetes management; lifestyle choices significantly impact blood sugar control. Common side effects include nausea, diarrhea, vomiting, stomach discomfort, headache, and throat irritation. Low blood sugar (hypoglycemia) is a potential side effect, especially when combined with insulin or sulfonylureas; learn to identify and manage hypoglycemic episodes. This medication isn't suitable for everyone. Inform your physician about any pre-existing kidney, liver, heart, or pancreatic conditions, or significant alcohol consumption before commencing treatment. Pregnant or nursing mothers should seek medical advice before use. Other medications may interact with Diabex Duo; provide a complete medication list to your doctor to ensure safety. Alcohol should be minimized due to its blood glucose-lowering effect. Your doctor will monitor your kidney function and blood sugar throughout treatment.

Uses of Sitawalk 50mg/500mg Tablet

Managing type 2 diabetes

Major Benefits of Sitawalk 50mg/500mg Tablet:

Consume this medication precisely as your physician directs, adhering to the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. The Sitawalk 50mg/500mg Tablet should be administered with a meal.

Common Side effects of Sitawalk 50mg/500mg Tablet:

  • Decreased appetite
  • Vomiting
  • Upper respiratory tract infection
  • Hypoglycemia (low blood glucose level)
  • Abdominal bloating
  • Nausea
  • Diarrhea

How to use Sitawalk 50mg/500mg Tablet:

Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and duration. Ingest the Sitawalk 50mg/500mg Tablet whole; avoid chewing, crushing, or fracturing it. Administer this medication with a meal.

How Sitawalk 50mg/500mg Tablet works:

Sitagliptin/metformin 50mg/500mg tablets combine two active ingredients to manage blood glucose. Sitagliptin enhances insulin production by the pancreas, improves insulin utilization, and decreases hepatic glucose output. Metformin, a biguanide, reduces liver glucose production, slows intestinal glucose absorption, and increases insulin sensitivity. This dual action leads to superior glycemic control.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Consuming alcohol alongside Sitawalk 50mg/500mg Tablet is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

Use of Sitawalk 50mg/500mg tablets during pregnancy may pose risks. While human research is scarce, animal studies indicate potential harm to a fetus. A physician will assess the advantages against possible risks prior to prescribing. Seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

The use of Sitawalk 50mg/500mg tablets while breastfeeding is likely inadvisable. Scant human evidence indicates potential transfer of the medication into breast milk, posing a possible risk to the infant.

DrivingDrivingCAUTION

Driving may be impaired by excessively high or low blood glucose levels. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Patients with kidney impairment should exercise caution when using Sitawalk 50mg/500mg tablets, potentially requiring dosage modification. Physician consultation is recommended. Sitawalk 50mg/500mg tablets are contraindicated in patients with severe kidney disease. Routine monitoring of renal function is advised during treatment.

LiverLiverUNSAFE

Individuals with liver conditions should likely avoid Sitawalk 50mg/500mg Tablets due to potential safety concerns. Medical advice is recommended.

What if you forget to take Sitawalk 50mg/500mg Tablet :

Should you forget to take a Sitawalk 50mg/500mg Tablet, administer it immediately. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Sitawalk 50mg/500mg Tablet

LabelValue
Developing Habits No.
Treatment Category Diabetes Medication

FAQs on Sitawalk 50mg/500mg Tablet

Sitawalk 50mg/500mg tablets combine sitagliptin and metformin to manage type 2 diabetes in adults. This medication improves blood sugar control when used with diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin increases insulin release by inhibiting DPP-4. This combination is not suitable for individuals under 18.
Prolonged Sitawalk 50mg/500mg Tablet use can lead to vitamin B12 deficiency by hindering its stomach absorption. This deficiency may cause anemia, nerve damage (manifesting as tingling, numbness in extremities, weakness, urinary issues, cognitive changes, and ataxia), if left unaddressed. To mitigate this risk, annual supplemental vitamin B12 is recommended by some researchers.
Sitawalk 50mg/500mg tablets may cause common side effects such as low blood sugar (hypoglycemia), altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects include lactic acidosis. Prolonged use can also result in vitamin B12 deficiency.
Sitawalk 50mg/500mg Tablets are contraindicated in patients with known allergies to any ingredient or excipient. Avoid use in patients with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Combining Sitawalk 50mg/500mg tablets with alcohol is unsafe and may heighten the risk of lactic acidosis.
Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
Sitagliptin/Metformin 50mg/500mg can cause lactic acidosis, a serious medical emergency resulting from excessive blood lactic acid (also known as MALA). This rare side effect is more likely in patients with kidney disease, older adults, or those who consume significant alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these, discontinue Sitagliptin/Metformin and seek immediate medical attention.
Sitawalk 50mg/500mg tablets combine sitagliptin and metformin to treat type 2 diabetes in adults. This combination improves blood sugar control when used with diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin increases insulin release by inhibiting DPP-4. It's not suitable for individuals under 18.
Sitawalk 50mg/500mg tablets may cause common side effects such as hypoglycemia, altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects include lactic acidosis. Prolonged use may also result in vitamin B12 deficiency.
Sitawalk 50mg/500mg Tablets are contraindicated in patients with known allergies to any ingredient or excipient. This medication should also be avoided by those with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Combining alcohol and Sitawalk 50mg/500mg tablets is unsafe and may heighten the risk of lactic acidosis.
Sitagliptin/Metformin (Sitawalk 50mg/500mg) can cause lactic acidosis (MALA, Metformin-associated lactic acidosis), a serious medical emergency due to excessive blood lactic acid. This rare side effect necessitates caution in patients with kidney disease, the elderly, or those who consume significant alcohol. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea/vomiting, abdominal pain, and bradycardia. If experienced, discontinue Sitawalk and seek immediate medical attention.
Prolonged Sitawalk 50mg/500mg Tablet use can lead to vitamin B12 deficiency by impairing its absorption. This deficiency, if left untreated, may cause anemia, neurological issues such as numbness and tingling in the extremities, weakness, urinary problems, cognitive changes, and ataxia. To mitigate this risk, annual supplemental vitamin B12 is recommended by some researchers.
Store this medication in its original, tightly closed container, as directed on the label or packaging. Dispose of any unused medication properly and keep it out of reach of children, pets, and others.
Sitawalk 50mg/500mg tablets combine sitagliptin and metformin to manage type 2 diabetes in adults. This combination improves blood sugar control when used with diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin increases insulin release by inhibiting DPP-4. This medication is not suitable for individuals under 18.
Sitawalk 50mg/500mg tablets may cause common side effects such as hypoglycemia, altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects, including lactic acidosis, are possible. Prolonged use can also result in vitamin B12 deficiency.
Patients with known allergies to Sitawalk 50mg/500mg Tablet components or excipients, or those with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis should not use this medication.
Combining Sitawalk 50mg/500mg tablets with alcohol is unsafe and may heighten the risk of lactic acidosis.
Sitagliptin/Metformin 50mg/500mg can cause lactic acidosis, a serious medical emergency resulting from excessive blood lactic acid (also known as MALA – Metformin-associated lactic acidosis). This rare side effect necessitates avoiding this medication in patients with kidney disease, the elderly, or those who consume significant alcohol. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If experienced, discontinue Sitagliptin/Metformin immediately and seek medical attention.
Prolonged use of Sitawalk 50mg/500mg Tablet can lead to vitamin B12 deficiency by impairing its absorption. This deficiency, if left untreated, may cause anemia, neurological issues such as numbness and tingling in the extremities, weakness, urinary problems, cognitive changes, and ataxia. To mitigate this risk, annual supplemental vitamin B12 is recommended by some researchers.
Store this medication in its original, tightly closed container, as directed on the label. Discard any unused medication. Keep it out of reach of children, pets, and others.
Sitawalk 50mg/500mg Table...
333